Source: http://www.wvlegislature.gov/Bill_status/bills_text.cfm?billdoc=SB6%20INTR.htm&yr=2014&sesstype=RS&i=6
Timestamp: 2018-12-11 16:16:39
Document Index: 188030291

Matched Legal Cases: ['§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60']

OTHER VERSIONS - Committee Substitute (2) | Engrossed Version | Committee Substitute (1) | | Email
[Introduced January 8, 2014; referred to the Committee on Health and Human Resources; and then to the Committee on the Judiciary.]
A BILL to repeal §60A-10-8 of the Code of West Virginia, 1931, as amended; to amend and reenact §60A-2-210 and §60A-2-212 of said code; and to amend and reenact §60A-10-2, §60A-10-3, §60A-10-4 and §60A-10-7 of said code, all relating to Methamphetamine Lab Eradication Act and prevention of production of methamphetamine; requiring certain drug products be obtained by prescription only; moving certain drug products from Schedule V to Schedule IV; providing exception for drug products that cannot be feasibly converted into methamphetamine; making legislative findings; defining terms; prohibiting pharmacies from selling certain drugs that can be used in production of methamphetamine without prescription; creating criminal offense for possession of certain substances without prescription with intent to transfer to another to make methamphetamine; permitting sale of certain drugs without prescription where Board of Pharmacy determines that drugs are not feasible for being used for manufacture of methamphetamine; updating maximum amounts persons are permitted to purchase of certain drugs that cannot feasibly be converted into methamphetamine; adjusting requirements of Multi-State Real-Time Tracking System; removing certain outdated language; and providing rule-making authority to Board of Pharmacy to implement emergency and legislative rules, which will provide procedures for which products may be sold over the counter and which require prescription and other information necessary to implement Methamphetamine Lab Eradication Act.
That §60A-10-8 of the Code of West Virginia, 1931, as amended, be repealed; that §60A-2-210 and §60A-2-212 of said code be amended and reenacted; and that §60A-10-2, §60A-10-3, §60A-10-4 and §60A-10-7 of said code be amended and reenacted, all to read as follows:
(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(d) Fenfluramine. Any material, compound, mixture or preparation which contains any quantity of the following substance, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible: Fenfluramine.
(e) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:
(f) Any compound, mixture or preparation containing as its single active ingredient ephedrine, pseudoephedrine or phenylpropanolamine, their salts or optical isomers, or salts of optical isomers except products which are for pediatric use primarily intended for administration to children under the age of twelve and products which have been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine, as set forth in article ten of this chapter: Provided, That neither the offenses set forth in section four hundred one, article four of this chapter, nor the penalties therein, shall be applicable to ephedrine, pseudoephedrine or phenylpropanolamine, which shall be subject to the provisions of article ten of this chapter.
(c) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture or preparation containing any of the following narcotic drugs or their salts calculated as the free anhydrous base or alkaloid in limited quantities as set forth below, which shall include one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
(e) That environmental damage is another consequence of the methamphetamine epidemic. Each pound of methamphetamine produced leaves behind five to six pounds of toxic waste. Chemicals and byproducts that result from the manufacture of methamphetamine are often poured into plumbing systems, storm drains or directly onto the ground. Clean up of methamphetamine laboratories is extremely resource-intensive, with an average remediation cost of $5,000.
(f) That it is in the best interest of every West Virginian to develop a viable solution to address the growing methamphetamine problem in the State of West Virginia. The Legislature finds that conversion-proof pseudoephedrine hydrocloride can provide an over-the-counter option that cannot be used in the manufacture of methamphetamine. The Legislature finds that requiring a prescription for restricting access to over-the-counter drugs that can be converted used to facilitate production of methamphetamine is necessary to protect the public safety of all West Virginians.
(b) "Designated precursor" means any drug product made subject to the requirements of this article by the provisions of section ten of this article.
(c) "Distributor" means any person within this state or another state, other than a manufacturer or wholesaler, who sells, delivers, transfers or in any manner furnishes a drug product to any person who is not the ultimate user or consumer of the product.
(f) "Manufacturer" means any person within this state who produces, compounds, packages or in any manner initially prepares for sale or use any drug product or any such person in another state if they cause the products to be compounded, packaged or transported into this state.
(h) “Multi-State Real-Time Tracking System” or “MSRTTS” means the real-time electronic logging system provided by NADDI at no cost to states that have legislation requiring real-time electronic monitoring of precursor purchases, and agree to use the system. MSRTTS is used by pharmacies and law enforcement to track sales of over-the-counter (OTC) cold and allergy medications containing precursors to the illegal drug, methamphetamine.
(l) "Pharmacist" means an individual currently licensed by this state to engage in the practice of pharmacist care as defined in article five, chapter thirty of this code.
(m) "Pharmacy intern" has the same meaning as the term "intern" as set forth in section one-b, article five, chapter thirty of this code.
(n) "Pharmacy" means any drugstore, apothecary or place within this state where drugs are dispensed and sold at retail or display for sale at retail and pharmacist care is provided outside of this state where drugs are dispensed and pharmacist care is provided to residents of this state.
(q) "Retail establishment" means any entity or person within this state who sells, transfers or distributes goods, including over-the-counter drug products, to an ultimate consumer.
(t) "Wholesaler" means any person within this state or another state, other than a manufacturer, who sells, transfers or in any manner furnishes a drug product to any other person in this state for the purpose of being resold.
§60A-10-4. Purchase, receipt, acquisition and possession of substances to be used as precursor to manufacture of methamphetamine or another controlled substance; offenses; exceptions; penalties.
(a) A pharmacy may not sell, transfer or dispense to the same person, and a person may not purchase more than three and six-tenths grams per day, more than seven and two-tenths grams in a thirty-day period or more than forty-eight grams annually of ephedrine, pseudoephedrine or phenylpropanolamine without a prescription, unless the product has been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine: Provided, That a pharmacy may not sell, transfer or dispense to the same person, and a person may not purchase more than three and six-tenths grams per day, more than seven and two-tenths grams in a thirty-day period or more than forty-eight grams annually of ephedrine, pseudoephedrine or phenylpropanolamine that has been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine. The limits shall apply to the total amount of ephedrine, pseudoephedrine and phenylpropanolamine contained in the products, and not the overall weight of the products.
(1) Any person who or knowingly purchases, receives or otherwise possesses more than seven and two-tenths grams in a thirty-day period of ephedrine, pseudoephedrine or phenylpropanolamine in any form without a prescription is guilty of a misdemeanor and, upon conviction, shall be confined in a jail for not more than one year, fined not more than $1,000, or both fined and confined.
(2) Any person who knowingly purchases, receives or otherwise possesses ephedrine, pseudoephedrine or phenylpropanolamine in any form with the intent to transfer the substance to someone that the person knows or should know will use the substance to manufacture methamphetamine is guilty of a misdemeanor and, upon conviction, shall be confined in a jail for not more than one year, fined not more than $1,000, or both fined and confined.
(2) (3) Any pharmacy, wholesaler or other entity operating the retail establishment which sells, transfers or dispenses a product in violation of this section is guilty of a misdemeanor and, upon conviction, shall be fined not more than $1,000 for the first offense, or more than $10,000 for each subsequent offense.
(b) Notwithstanding the provisions of subdivision (a)(1) subdivisions (1) and (2) of subsection (a) of this section, any person convicted of a second or subsequent violation of the provisions of said subdivisions or a statute or ordinance of the United States or another state which contains the same essential elements is guilty of a felony and, upon conviction, shall be imprisoned in a state correctional facility for not less than one nor more than five years, fined not more than $25,000, or both imprisoned and fined.
(4) (3) Persons lawfully possessing drug products in their capacities as distributors, wholesalers, manufacturers, pharmacists, pharmacy interns, pharmacy technicians, or health care professionals.
(d) Notwithstanding any provision of this code to the contrary, any person who knowingly possesses any amount of ephedrine, pseudoephedrine, phenylpropanolamine or other designated precursor with the intent to use it in the manufacture of methamphetamine, who knowingly compensates, hires or provides other incentives for another person to purchase, obtain or transfer any amount of ephedrine, pseudoephedrine, phenylpropanolamine or other designated precursor with the intent to use it in the manufacture of methamphetamine or who knowingly possesses a substance containing ephedrine, pseudoephedrine or phenylpropanolamine or their salts, optical isomers or salts of optical isomers in a state or form which is, or has been altered or converted from the state or form in which these chemicals are, or were, commercially distributed is guilty of a felony and, upon conviction, shall be imprisoned in a state correctional facility for not less than two nor more than ten years, fined not more than $25,000, or both imprisoned and fined.
(3) In addition to any administrative penalties provided by law, any violation of this subsection is a misdemeanor, punishable upon conviction by a fine in an amount not more than $10,000.§60A-10-7. Restricted products; rule-making authority.
(a) On or before July 1, 2014, 2005 the Board of Pharmacy shall promulgate emergency and legislative rules pursuant to the provision of article three, chapter twenty-nine-a of this code to implement continue the a program wherein the Board of Pharmacy shall consult consults with the Superintendent of the State Police in identifying drug products which are a designated precursor, in addition to those that contain ephedrine, pseudoephedrine or phenylpropanolamine, that are commonly being used in the production and distribution of methamphetamine. Those drug products which the Superintendent of the State Police have demonstrated by empirical evidence are commonly used in the manufacture of methamphetamine shall be added to a supplemental list and shall be subject to all of the restrictions of this article. These rules established pursuant to this section shall include:
(1) A process whereby pharmacies are made aware of all drug products that contain ephedrine, pseudoephedrine and phenylpropanolamine that will be listed as a Schedule V substance and must be sold, transferred or dispensed from behind a pharmacy counter. This process shall specifically state which products have been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine and may, therefore, be sold without a prescription. The process shall specify that all other drug products which have not been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine may be distributed by prescription only;
(2) A process whereby pharmacies and retail establishments are made aware of additional drug products added to Schedule V, including whether that product has been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine, that are required to be placed behind the pharmacy counter for sale, transfer or distribution can be periodically reviewed and updated.
(b) At any time after July 1, 2005, the Board of Pharmacy, upon the recommendation of the Superintendent of the State Police, shall promulgate emergency and legislative rules pursuant to the provision of article three, chapter twenty-nine-a of this code to implement an updated supplemental list of products containing the controlled substances ephedrine, pseudoephedrine or phenylpropanolamine as an active ingredient or any other drug used as a precursor in the manufacture of methamphetamine, which the Superintendent of the State Police has demonstrated by empirical evidence is being used in the manufacture of methamphetamine. This list shall also note any products containing ephedrine, pseudoephedrine or phenylpropanolamine as an active ingredient but which has been determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine. This listing process shall comport with the requirements of subsection (a) of this section.
NOTE: The purpose of this bill is to allow for the sale of drug products determined by the Board of Pharmacy to be in a form which is not feasible for being used for the manufacture of methamphetamine to be sold in an over-the-counter transaction, while requiring drug products that may be converted to use in the manufacture of methamphetamine to be sold by prescription only.